Evaluation on the effects of hyaluronan combined with different dosages of celecoxib for relieving pain and ankylosis induced by knee osteoarthritis

Chinese Journal of Clinical Rehabilitation

Volumn 8, Issue 26, 2004, Pages 5491-5493

  Wu, Hong Bin ^a   Du, Jing Yuan ^a   Yang, Shu Hua ^a   Shao, Zeng Wu ^a   Xiong, Xiao Qian ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; HYALURONIC ACID;

ANKYLOSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; KNEE OSTEOARTHRITIS; KNEE PAIN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PATIENT SATISFACTION; SCORING SYSTEM; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

EID: 4944266667     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Chard J, Dieppe P. Update: treatment of osteoarthritis. Arthritis Rheum 2002; 15; 47(6): 686-90
2. Geis GS. Update on clinical developments with Celocoxib, a new specific COX-2 inhibitor: what can we expect. J Rheumatol 1999;26(suppl 56): 31-6
3. Chinese source 2003, 7(14): 2053
4. Chinese source 2001: 678
5. Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; 15(12): 1833-40
6. Rovati LC, Annefeld M, Giacovelli G, et al. Glucosamine in osteoarthritis. Lancet 1999; 354(9190): 1640
7. Kitahara M, Eitner F, Ostendorf T, et al. Selective cyclooxygenase-2 inhibition impairs glomerular capillary healing in experimental glomerulonephritis. J Am Soc Nephrol 2002; 13(5): 1261-70
8. Chinese source 2002, 6(8): 1202-3
9. Chinese source 2002, 6(8): 1204-5